Inventor · disambiguated record
Keith R. Walley
Also filed as: WALLEY KEITH R
1 granted patent·15 pending applications·1 citations·filing 2003–2022
17Inventor score
Files withUNIV BRITISH COLUMBIA5RUSSELL JAMES3WALLEY KEITH R3RUSSELL JAMES A2ANJI PHARMACEUTICALS INC1
Top patents by PatentIndex Score
16 records- 0161US7820376B2Protein C polymorphismsUNIV BRITISH COLUMBIA·Filed 2003·Granted Oct 26, 2010·1 cites·8 claims
- 0261US2023066056A1Methods and uses for proprotein convertase subtilisin kexin 9 (pcsk9) inhibitorsANJI PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0348US2006246451A1Plasminogen activator inhibitor-1 (pai-1) haplotypes useful as indicators of patient outcomeRUSSELL JAMES A·Filed 2004·Application pending·0 cites
- 0443US2011104683A1Plasminogen activator inhibitor-1 (pai-1) haplotypes useful as indicators of patient outcomeUNIV BRITISH COLUMBIA·Filed 2010·Application pending·0 cites
- 0543US2009298711A1Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjectsUNIV BRITISH COLUMBIA·Filed 2007·Application pending·0 cites
- 0643US2011020825A1Protein c polymorphisms useful as an indicator of patient outcomeUNIV BRITISH COLUMBIA·Filed 2010·Application pending·0 cites
- 0741US2015140005A1Methods and Uses for Proprotein Convertase Subtilisin Kexin 9 (PCSK9) InhibitorsCYON THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 0841US2011171200A1Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compoundWALLEY KEITH R·Filed 2009·Application pending·0 cites
- 0939US2010209413A1Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of deathWALLEY KEITH R·Filed 2008·Application pending·0 cites
- 1038US2011110930A1Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) Polymorphisms As Indicators of Subject Outcome in Critically Ill SubjectsWALLEY KEITH R·Filed 2008·Application pending·0 cites
- 1138US2007281300A1Thrombomodulin (Thbd) Haplotypes Predict OutcomeRUSSELL JAMES·Filed 2005·Application pending·0 cites
- 1237US2010041600A1Interferon gamma polymorphisms as indicators of subject outcome in critically ill subjectsRUSSEL JAMES A·Filed 2007·Application pending·0 cites
- 1335US2009148458A1Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapyUNIV BRITISH COLUMBIA·Filed 2006·Application pending·0 cites
- 1432US2009176206A1Toll-like receptor 2 (tlr-2) haplotypes predict outcome of patientsRUSSELL JAMES·Filed 2005·Application pending·0 cites
- 1532US2008026371A1Protein C And Endothelial Protein C Receptor Polymorphisms As Indicators Of Subject OutcomeRUSSELL JAMES·Filed 2005·Application pending·0 cites
- 1631US2011027184A1Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c-like compound administrationRUSSELL JAMES A·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Keith R. Walley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →